A Broad-Spectrum Antiviral Molecule, QL47, Selectively Inhibits Eukaryotic Translation

Journal of Biological Chemistry - United States
doi 10.1074/jbc.ra119.011132
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Biochemistry & Molecular Biology (ASBMB)

Related search

Broad-Spectrum Coronavirus Antiviral Drug Discovery

Expert Opinion on Drug Discovery
Drug Discovery
2019English

Tilorone: A Broad-Spectrum Antiviral for Emerging Viruses

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2020English

Broad-Spectrum Antiviral Agents: A Crucial Pandemic Tool

Expert Review of Anti-Infective Therapy
VirologyInfectious DiseasesMicrobiology
2019English

KAT8 Selectively Inhibits Antiviral Immunity by Acetylating IRF3

Journal of Experimental Medicine
MedicineAllergyImmunology
2019English

Broad-Spectrum Antiviral Activity of 2-Beta-D-Ribofuranosylselenazole-4-Carboxamide, a New Antiviral Agent.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1983English

Broad-Spectrum Synergistic Antiviral Activity of Selenazofurin and Ribavirin.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1984English

Polymer-Mediated Broad Spectrum Antiviral Prophylaxis: Utility in High Risk Environments

2011English

Identification of Small Molecule Enzyme Inhibitors as Broad-Spectrum Anthelmintics

Scientific Reports
Multidisciplinary
2019English

The Transformation Suppressor Pdcd4 Is a Novel Eukaryotic Translation Initiation Factor 4A Binding Protein That Inhibits Translation

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy